Theresa Dornieden1, Arne Sattler1, Anna Pascual-Reguant2, Annkathrin Helena Ruhm1, Lion Gabriel Thiel1, Yasmin Samira Bergmann1, Linda Marie Laura Thole1, Ralf Köhler2, Anja Andrea Kühl3, Anja Erika Hauser2,4, Sengül Boral5, Frank Friedersdorff6, Katja Kotsch7. 1. Department of General and Visceral Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 2. German Rheumatism Research Centre Berlin, Leibniz Institute, Berlin, Germany. 3. iPath.Berlin-Immunopathology for Experimental Models, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 4. Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 5. Department of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. 6. Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 7. Department of General and Visceral Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany katja.kotsch@charite.de.
Abstract
BACKGROUND: Tissue-resident memory T (TRM) cells are known to be important for the first line of defense in mucosa-associated tissues. However, the composition, localization, effector function, and specificity of TRM cells in the human kidney and their relevance for renal pathology have not been investigated. METHODS: Lymphocytes derived from blood, renal peritumor samples, and tumor samples were phenotypically and functionally assessed by applying flow cytometry and highly advanced histology (multi-epitope ligand cartography) methods. RESULTS: CD69+CD103+CD8+ TRM cells in kidneys display an inflammatory profile reflected by enhanced IL-2, IL-17, and TNFα production, and their frequencies correlate with increasing age and kidney function. We further identified mucosa-associated invariant T and CD56dim and CD56bright natural killer cells likewise expressing CD69 and CD103, the latter significantly enriched in renal tumor tissues. CD8+ TRM cell frequencies were not elevated in kidney tumor tissue, but they coexpressed PD-1 and TOX and produced granzyme B. Tumor-derived CD8+ TRM cells from patients with metastases were functionally impaired. Both CD69+CD103-CD4+ and CD69+CD103-CD8+ TRM cells form distinct clusters in tumor tissues in proximity to antigen-presenting cells. Finally, EBV, CMV, BKV, and influenza antigen-specific CD8+ T cells were enriched in the effector memory T cell population in the kidney. CONCLUSIONS: Our data provide an extensive overview of TRM cells' phenotypes and functions in the human kidney for the first time, pointing toward their potential relevance in kidney transplantation and kidney disease.
BACKGROUND: Tissue-resident memory T (TRM) cells are known to be important for the first line of defense in mucosa-associated tissues. However, the composition, localization, effector function, and specificity of TRM cells in the human kidney and their relevance for renal pathology have not been investigated. METHODS: Lymphocytes derived from blood, renal peritumor samples, and tumor samples were phenotypically and functionally assessed by applying flow cytometry and highly advanced histology (multi-epitope ligand cartography) methods. RESULTS: CD69+CD103+CD8+ TRM cells in kidneys display an inflammatory profile reflected by enhanced IL-2, IL-17, and TNFα production, and their frequencies correlate with increasing age and kidney function. We further identified mucosa-associated invariant T and CD56dim and CD56bright natural killer cells likewise expressing CD69 and CD103, the latter significantly enriched in renal tumor tissues. CD8+ TRM cell frequencies were not elevated in kidney tumor tissue, but they coexpressed PD-1 and TOX and produced granzyme B. Tumor-derived CD8+ TRM cells from patients with metastases were functionally impaired. Both CD69+CD103-CD4+ and CD69+CD103-CD8+ TRM cells form distinct clusters in tumor tissues in proximity to antigen-presenting cells. Finally, EBV, CMV, BKV, and influenza antigen-specific CD8+ T cells were enriched in the effector memory T cell population in the kidney. CONCLUSIONS: Our data provide an extensive overview of TRM cells' phenotypes and functions in the human kidney for the first time, pointing toward their potential relevance in kidney transplantation and kidney disease.
Authors: Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley Journal: J Leukoc Biol Date: 2013-09-04 Impact factor: 4.962
Authors: Anusha-Preethi Ganesan; James Clarke; Oliver Wood; Eva M Garrido-Martin; Serena J Chee; Toby Mellows; Daniela Samaniego-Castruita; Divya Singh; Grégory Seumois; Aiman Alzetani; Edwin Woo; Peter S Friedmann; Emma V King; Gareth J Thomas; Tilman Sanchez-Elsner; Pandurangan Vijayanand; Christian H Ottensmeier Journal: Nat Immunol Date: 2017-06-19 Impact factor: 25.606
Authors: Denis Schapiro; Hartland W Jackson; Swetha Raghuraman; Jana R Fischer; Vito R T Zanotelli; Daniel Schulz; Charlotte Giesen; Raúl Catena; Zsuzsanna Varga; Bernd Bodenmiller Journal: Nat Methods Date: 2017-08-07 Impact factor: 28.547
Authors: Omar Khan; Josephine R Giles; Sierra McDonald; Sasikanth Manne; Shin Foong Ngiow; Kunal P Patel; Michael T Werner; Alexander C Huang; Katherine A Alexander; Jennifer E Wu; John Attanasio; Patrick Yan; Sangeeth M George; Bertram Bengsch; Ryan P Staupe; Greg Donahue; Wei Xu; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Jonathan Kaye; Shelley L Berger; E John Wherry Journal: Nature Date: 2019-06-17 Impact factor: 49.962
Authors: Anne E Carpenter; Thouis R Jones; Michael R Lamprecht; Colin Clarke; In Han Kang; Ola Friman; David A Guertin; Joo Han Chang; Robert A Lindquist; Jason Moffat; Polina Golland; David M Sabatini Journal: Genome Biol Date: 2006-10-31 Impact factor: 13.583
Authors: Joost Smolders; Kirstin M Heutinck; Nina L Fransen; Ester B M Remmerswaal; Pleun Hombrink; Ineke J M Ten Berge; René A W van Lier; Inge Huitinga; Jörg Hamann Journal: Nat Commun Date: 2018-11-02 Impact factor: 14.919
Authors: Loreto Parga-Vidal; Michiel C van Aalderen; Regina Stark; Klaas P J M van Gisbergen Journal: Nat Rev Nephrol Date: 2022-01-25 Impact factor: 28.314
Authors: Łukasz Zapała; Michał Kunc; Sumit Sharma; Rafał Pęksa; Marta Popęda; Wojciech Biernat; Piotr Radziszewski Journal: J Cancer Res Clin Oncol Date: 2022-08-30 Impact factor: 4.322
Authors: Michiel G H Betjes; Frederique Prevoo; Thierry P P van den Bosch; Mariska Klepper; Nicolle H R Litjens Journal: Cells Date: 2022-07-18 Impact factor: 7.666